IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.
- DOI
- 10.1177/1759720x261460108
- Published
- 2026
- Container
- Therapeutic advances in musculoskeletal disease
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1177/1759720x261460108,
title = {IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.},
author = {Paci V and Foti R and Pantano I and Carletto A and Celletti E and Miceli GF and Cangemi I and Lopalco G and Montalbano S and Chimenti MS and Picchianti Diamanti A and Massafra U and Filippucci E and Parisi A and Leccese P and Panaccione A and Puca I and Amato G and Marrone S and Di Penta M and Corrao S and Cela E and Rai A and Tirri E and Iannone F and Atzeni F and Rossini M and Ciccia F and Foti R and Moroncini G and Luchetti Gentiloni MM},
year = {2026},
journal = {Therapeutic advances in musculoskeletal disease},
doi = {10.1177/1759720x261460108},
url = {https://doi.org/10.1177/1759720x261460108}
}RIS
TY - JOUR TI - IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence. AU - Paci V AU - Foti R AU - Pantano I AU - Carletto A AU - Celletti E AU - Miceli GF AU - Cangemi I AU - Lopalco G AU - Montalbano S AU - Chimenti MS AU - Picchianti Diamanti A AU - Massafra U AU - Filippucci E AU - Parisi A AU - Leccese P AU - Panaccione A AU - Puca I AU - Amato G AU - Marrone S AU - Di Penta M AU - Corrao S AU - Cela E AU - Rai A AU - Tirri E AU - Iannone F AU - Atzeni F AU - Rossini M AU - Ciccia F AU - Foti R AU - Moroncini G AU - Luchetti Gentiloni MM PY - 2026 JO - Therapeutic advances in musculoskeletal disease DO - 10.1177/1759720x261460108 UR - https://doi.org/10.1177/1759720x261460108 ER -
APA
V, P., R, F., I, P., A, C., E, C., GF, M., I, C., G, L., S, M., MS, C., A, P. D., U, M., E, F., A, P., P, L., A, P., I, P., G, A., S, M., M, D. P., S, C., E, C., A, R., E, T., F, I., F, A., M, R., F, C., R, F., G, M., & MM, L. G. (2026). IMPACT study: large real-world evaluation of guselkumab in psoriatic arthritis integrating clinical response and treatment persistence.. Therapeutic advances in musculoskeletal disease. https://doi.org/10.1177/1759720x261460108
Source records
- pubmed · retrieved 2026-09-25T12:48:00.091Z